SAGE, a national programme to recognise excellence in gastroenterology, is now accepting entries for 2016
Friday, 05 February 2016 11:06
The Shire Awards for Gastrointestinal Excellence - SAGE, is now accepting entries for 2016. This is the 6th year of this independently adjudicated educational programme, which is organised and funded by Shire, and designed to allow individual healthcare professionals, units and healthcare networks in gastrointestinal (GI) care to be recognised for innovative work, share best practice and raise standards of patient care. Three grant donations will be awarded up to the amount of £10,000, £5,000 and £3,000, dependent on the projects requirements, for use towards furthering the development of the winning projects.
Applications must be consultant led and will be accepted from all professional groups working in GI care, including patient representative groups working in collaboration with clinical teams. Collaborative projects bringing together professionals from two or more health board areas or across specialities, disciplines or sectors are also welcomed.
The judging panel, who have been selected by Shire due to their expertise in gastroenterology and as past winners of SAGE, will oversee the evaluation, assessment and awarding of SAGE and will be looking for entries that show innovation in the field of GI care and a significant improvement in patient care. The judging panel's assessment of entries, selection of evaluation criteria, meetings, deliberations and decisions are entirely independent of Shire.
IBD Registry News - February 2016
Monday, 01 February 2016 12:39
Submit your data
The IBD Registry is growing! Last time round, 8 hospitals submitted information on 8,037 IBD patients. The next submission opportunity is coming up at the end of January, when we hope that 5 more sites will submit their data for the first time. Another 6 teams are already in the process of registering with HSCIC to participate next quarter. The deadline for January data is Friday 5th February.
In other good news, we now have the go-ahead to appoint a data manager, so we hope to be able to provide sites submitting data in April with a first local report. We envisage this first report describing the demographic and clinical profiles of patients in the Registry, with analysis and interpretation becoming gradually more possible over time as the patient data becomes more complete.
Regional meetings update
We held meetings in London, Cardiff and Taunton in January, so we've now met with over 120 members of IBD clinical teams, and look forward to meeting more in Birmingham, Darlington and Glasgow. Slides are available at http://ibdregistry.org.uk/workshops/
Many teams are preparing business cases to support obtaining a patient management system or database; if you need help writing your business case, there's an example here http://ibdregistry.org.uk/wp-content/uploads/2014/08/3.-Business-case-example.pdf. With different data entry options available, if you're thinking of opting for a patient management system it's worth contacting suppliers (CIMS, Emis Health etc) direct to get an accurate cost estimate for your trust or hospital.
There are some places available at the following meetings:
BIRMINGHAM Friday 5th February Chair: Prof Tariq Iqbal
DARLINGTON Tuesday 1st March Chair: Dr John Mansfield
GLASGOW Wednesday 20th April Chair: Dr Ian Arnott
We'd really encourage you to attend, and to bring your team if you can. There is no charge to attend, thanks to support from Tillotts, Takeda, Janssen and Shire. For more information and to register please go to http://ibdregistry.org.uk/
UK NSC recommendation on Bowel Cancer screening in adults
Tuesday, 19 January 2016 14:45
Following evaluation and consultation, that BSG fed in to, the UK National Screening Committee (NSC) has recommended a change to the test used in the Bowel Cancer Screening Programmes. UK NSC has announced that the use of Faecal Immunochemical Test as the primary test for bowel cancer should replace guaiac Faecal Occult Blood Test. UK NSC has also indicated that as colonoscopy capacity grows or screening uptake increases, the programmes should review and recommend alteration of the cut offs to increase the number of cancers detected.
Do you treat children with Hirschsprung's or Gastroschisis?
Wednesday, 06 January 2016 09:14
Would you be interested in sharing your expertise, improving the quality of research, and helping to improve outcomes in both conditions? NETS (Next stage in Evidence-based paediatric surgical Treatment Strategies), are developing core outcome sets for Hirschsprung's Disease and gastroschisis, and need doctors, nurses, allied health professionals, parents and patients to help us by completing three online questionnaires over the next 6 months. For more information and to register your interest, please go to www.npeu.ox.ac.uk/nets/taking-part
Page 1 of 6